Developments in artificial intelligence methods allow more accurate prediction of protein structures, potentially enabling researchers to target previously inaccessible protein molecules.
Patients with chronic obstructive pulmonary disease may develop acute exacerbation, a complication that is characterized by increased symptom severity.
These products are often available and/or used in combination, making it difficult to assess associations between adverse effects and a specific component of a particular agent.
As patients become more motivated to take charge of their health, the use of dietary supplements to help treat hypertension and dyslipidemia is increasing.
As new medications with complex mechanisms of action become available for orphan diseases, pharmacists are needed to provide patient and provider education and to ensure safety.